172 related articles for article (PubMed ID: 1565179)
1. Beta-2-microglobulin-derived amyloidosis: onset, distribution and clinical features in 13 hemodialysed patients.
Stein G; Schneider A; Thoss K; Ritz E; Linke RP; Schaefer K; Sperschneider H; Abendroth K; Fünfstück R
Nephron; 1992; 60(3):274-80. PubMed ID: 1565179
[TBL] [Abstract][Full Text] [Related]
2. Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients.
Stein G; Schneider A; Thoss K; Ritz E; Schaefer K; Hüller M; Sperschneider H; Marzoll I
Nephrol Dial Transplant; 1991; 6 Suppl 3():57-61. PubMed ID: 1775270
[TBL] [Abstract][Full Text] [Related]
3. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
4. Beta 2-microglobulin amyloidosis in hemodialysis patients. An autopsy study of intervertebral disks and posterior longitudinal ligaments.
Honda K; Hara M; Ogura Y; Nihei H; Mimura N
Acta Pathol Jpn; 1990 Nov; 40(11):820-6. PubMed ID: 2127652
[TBL] [Abstract][Full Text] [Related]
5. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis.
Garbar C; Jadoul M; Noël H; van Ypersele de Strihou C
Kidney Int; 1999 May; 55(5):1983-90. PubMed ID: 10231463
[TBL] [Abstract][Full Text] [Related]
6. Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column.
Ohashi K; Hara M; Kawai R; Ogura Y; Honda K; Nihei H; Mimura N
Kidney Int; 1992 Jun; 41(6):1646-52. PubMed ID: 1501421
[TBL] [Abstract][Full Text] [Related]
7. [Serum level and organ deposits of beta 2-microglobulin in dialysis patients].
Stein G; Schneider A; Toss H; Linke R; Schaefer K; Ritz E
Klin Wochenschr; 1990 Nov; 68(22):1150-5. PubMed ID: 2280578
[TBL] [Abstract][Full Text] [Related]
8. Hemodialysis-associated amyloidosis and beta-2 microglobulin. Clinical and immunohistochemical study.
Bardin T; Zingraff J; Shirahama T; Noel LH; Droz D; Voisin MC; Drueke T; Dryll A; Skinner M; Cohen AS
Am J Med; 1987 Sep; 83(3):419-24. PubMed ID: 3310621
[TBL] [Abstract][Full Text] [Related]
9. [Morphogenesis of beta 2m (A beta 2m) amyloid deposits in dialysis patients].
van Ypersele de Strihou C
Bull Mem Acad R Med Belg; 2000; 155(7-9):273-8; discussion 278-80. PubMed ID: 11388020
[TBL] [Abstract][Full Text] [Related]
10. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
Prinseau J; Baglin A; Benoit J; Leparc JM; Got C; Louis MF; Attar B; Fritel D
Ann Med Interne (Paris); 1989; 140(2):94-8. PubMed ID: 2662855
[TBL] [Abstract][Full Text] [Related]
11. [Osteoarticular amyloidosis caused by dialysis].
Orzincolo C; Bedani PL; Scutellari PN; Cardona P; Farinelli A; Vita G
Radiol Med; 1988; 76(1-2):38-43. PubMed ID: 3399708
[TBL] [Abstract][Full Text] [Related]
12. Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature.
Gal R; Korzets A; Schwartz A; Rath-Wolfson L; Gafter U
Arch Pathol Lab Med; 1994 Jul; 118(7):718-21. PubMed ID: 8024407
[TBL] [Abstract][Full Text] [Related]
13. Beta 2-microglobulin-related amyloidosis: where do we stand?
Gejyo F; Arakawa M
Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
[No Abstract] [Full Text] [Related]
14. Dialysis-related beta 2 microglobulin-amyloid arthropathy. Improvement of clinical symptoms after a switch of dialysis membranes.
Hardouin P; Flipo RM; Foissac-Gegoux P; Dumont A; Duquesnoy B; Delcambre B
Clin Rheumatol; 1988 Mar; 7(1):41-5. PubMed ID: 3044672
[TBL] [Abstract][Full Text] [Related]
15. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
[TBL] [Abstract][Full Text] [Related]
16. Electron microscopic characteristics of beta2-microglobulin amyloid deposits in long-term haemodialysis.
Bély M; Kapp P; Szabó TS; Lakatos T; Apáthy A
Ultrastruct Pathol; 2005; 29(6):483-91. PubMed ID: 16316949
[TBL] [Abstract][Full Text] [Related]
17. Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.
Gorevic PD; Munoz PC; Casey TT; DiRaimondo CR; Stone WJ; Prelli FC; Rodrigues MM; Poulik MD; Frangione B
Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7908-12. PubMed ID: 3532124
[TBL] [Abstract][Full Text] [Related]
18. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.
Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR
Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180
[TBL] [Abstract][Full Text] [Related]
19. Haemodialysis-associated beta 2M amyloidosis: current controversies.
Stein G; Sperschneider H; Fünfstück R; Ritz E
Nephrol Dial Transplant; 1994; 9 Suppl 3():48-50. PubMed ID: 8072726
[TBL] [Abstract][Full Text] [Related]
20. Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin.
Floege J; Burchert W; Brandis A; Gielow P; Nonnast-Daniel B; Spindler E; Hundeshagen H; Shaldon S; Koch KM
Kidney Int; 1990 Dec; 38(6):1169-76. PubMed ID: 2074658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
